NCT07890493

Immune Checkpoint Blockade and Chemotherapy With or Without Fecal Microbiota Transplant in Advanced Non-Small Cell Lung Cancer

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-12-31Est. Completion: 2030-12-31

Enrollment target: 160 participants

Contact

Lung NeoplasmsNeoadjuvant TherapyImmunotherapyMinimal Residual Disease

This study is a prospective single-arm clinical trial targeting patients with stage IB-IIIA non-small cell lung cancer (…

Beijing, ChinaEst. completion Oct 31, 2027

Non-small Cell Lung Cancer Stage IV

The goal of this clinical trial is to confirm that SB27 works in the same way as Keytruda in metastatic non-squamous non…

Banja Luka, Bosnia and HerzegovinaEst. completion Mar 10, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.